EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study

Leticia Iglesias, Rocío Vílchez, Santiago Aguín, Ramón García, Carolina Pena, Alberto Carral, Gerardo Huidobro, Aurea Molina, Jesús García Gómez, Marta Covela, Marinha Costa, Ana Medina

Anticancer Research · 2025

DOI: 10.21873/anticanres.17505 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Anticancer Research, 2025. Verfasst von Leticia Iglesias und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain; leticia.iglesias.rey@sergas.es. Hauptthemen laut MEDLINE: Nivolumab, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Antineoplastic Agents, Immunological.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NivolumabSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsAntineoplastic Agents, ImmunologicalNeoplasm Recurrence, LocalHumansMiddle AgedMaleFemaleAgedRetrospective StudiesAdultAged, 80 and overTreatment OutcomeProgression-Free SurvivalNeoplasm Metastasis

Stichwörter der Autor:innen

Nivolumabadverse eventsreal-life datarecurrent or metastatic diseasesquamous cell carcinoma of the head and neck

Substanzen

NivolumabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain; leticia.iglesias.rey@sergas.es.
  • Department of Medical Oncology, Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain.
  • Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), A Coruña, Spain.
  • Department of Medical Oncology, Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
  • Department of Medical Oncology, Fundación Centro Oncológico de Galicia (COG), A Coruña, Spain.
  • Department of Medical Oncology, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain.

Zitieren

APA

Iglesias, L., Vílchez, R., Aguín, S., García, R., Pena, C., Carral, A., Huidobro, G., Molina, A., Gómez, J. G., Covela, M., Costa, M., & Medina, A. (2025). Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study. Anticancer Research. https://doi.org/10.21873/anticanres.17505

Vancouver

Iglesias L, Vílchez R, Aguín S, García R, Pena C, Carral A, et al. Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study. Anticancer Research. 2025. doi:10.21873/anticanres.17505

BibTeX
@article{Iglesias2025,
  author = {Iglesias, Leticia and Vílchez, Rocío and Aguín, Santiago and García, Ramón and Pena, Carolina and Carral, Alberto and Huidobro, Gerardo and Molina, Aurea and Gómez, Jesús García and Covela, Marta and Costa, Marinha and Medina, Ana},
  title = {Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17505}
}
Kostenlos starten →